62 related articles for article (PubMed ID: 31731177)
1. Preparation of [
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Nucl Med Biol; 2019; 78-79():31-40. PubMed ID: 31731177
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [
Migliari S; Sammartano A; Boss M; Gotthardt M; Scarlattei M; Baldari G; Silva C; Bonadonna RC; Ruffini L
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056858
[No Abstract] [Full Text] [Related]
3. Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
Kumar N; Sharma AK; Guleria M; Shelar SB; Chakraborty A; Rakshit S; Kolay S; Satpati D; Das T
Mol Pharm; 2024 May; 21(5):2351-2364. PubMed ID: 38477252
[TBL] [Abstract][Full Text] [Related]
4. Intricacies in the Preparation of Patient Doses of [
Chakraborty A; Mitra A; Sahu S; Tawate M; Lad S; Kamaldeep ; Rakshit S; Upadhye Bannore T; Gaikwad S; Dhotre G; Ray MK; Damle A; Basu S; Banerjee S
Mol Imaging Biol; 2024 Feb; 26(1):61-80. PubMed ID: 37673943
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.
Velikyan I; Bulenga TN; Selvaraju R; Lubberink M; Espes D; Rosenström U; Eriksson O
Am J Nucl Med Mol Imaging; 2015; 5(2):109-26. PubMed ID: 25973333
[TBL] [Abstract][Full Text] [Related]
6. Formulation of patient dose of [
Amirdhanayagam J; Guleria M; Sharma R; Kumar N; Mukherjee A; Das T
J Labelled Comp Radiopharm; 2024 Apr; 67(4):131-144. PubMed ID: 38342496
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of no-carrier-added
Gracheva N; Müller C; Talip Z; Heinitz S; Köster U; Zeevaart JR; Vögele A; Schibli R; van der Meulen NP
EJNMMI Radiopharm Chem; 2019 Jul; 4(1):12. PubMed ID: 31659528
[TBL] [Abstract][Full Text] [Related]
8. Automated production of [
Kraihammer M; von Guggenberg E; Hörmann AA; Gabriel M; Decristoforo C
Nucl Med Biol; 2023; 124-125():108381. PubMed ID: 37634398
[TBL] [Abstract][Full Text] [Related]
9. A Proof-of-Concept Study on the Theranostic Potential of
Chen X; Tan F; Liang R; Liao J; Yang J; Lan T; Yang Y; Liu N; Li F
Chemistry; 2024 Feb; 30(9):e202303298. PubMed ID: 38050716
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Radiolabeling with
Okarvi SM
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004416
[TBL] [Abstract][Full Text] [Related]
11. Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.
Yue X; Kiesewetter DO; Guo J; Sun Z; Zhang X; Zhu L; Niu G; Ma Y; Lang L; Chen X
Bioconjug Chem; 2013 Jul; 24(7):1191-200. PubMed ID: 23750453
[TBL] [Abstract][Full Text] [Related]
12. Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog.
Roberts S; Khera E; Choi C; Navaratna T; Grimm J; Thurber GM; Reiner T
J Nucl Med; 2021 Jun; 62(6):839-848. PubMed ID: 33097631
[TBL] [Abstract][Full Text] [Related]
13. Formulation and clinical translation of [
Guleria M; Sharma R; Amirdhanayagam J; Sarma HD; Rangarajan V; Dash A; Das T
RSC Med Chem; 2021 Mar; 12(2):263-277. PubMed ID: 34046615
[TBL] [Abstract][Full Text] [Related]
14. 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.
Ogbomo SM; Shi W; Wagh NK; Zhou Z; Brusnahan SK; Garrison JC
Nucl Med Biol; 2013 Jul; 40(5):606-17. PubMed ID: 23622691
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Patient Doses of [
Nanabala R; Pillai MRA; Gopal B
Nucl Med Mol Imaging; 2022 Dec; 56(6):313-322. PubMed ID: 36425271
[TBL] [Abstract][Full Text] [Related]
16. Radiolabelled
Cieslik PA; Klingler S; Nolff M; Holland JP
Chemistry; 2024 Mar; 30(14):e202303805. PubMed ID: 38064536
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of β-cell-dependent contrast enhancement in the pancreas.
Clough TJ; Baxan N; Coakley EJ; Rivas C; Zhao L; Leclerc I; Martinez-Sanchez A; Rutter GA; Long NJ
Dalton Trans; 2020 Apr; 49(15):4732-4740. PubMed ID: 32207493
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of
Deiser S; Drexler M; Moreno-Alcántar G; Irl M; Schmidt C; Günther T; Casini A
Inorg Chem; 2023 Dec; 62(50):20710-20720. PubMed ID: 37556427
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the relative biological effectiveness (RBE) of the Lu-DOTA-iPSMA177 radiopharmaceutical.
de la Fuente-Mendoza JE; Azorín-Vega EP; Mendoza-Nava HJ; Rodríguez-Martínez G; Rodríguez-Dorantes M
Appl Radiat Isot; 2023 Dec; 202():111065. PubMed ID: 37879244
[TBL] [Abstract][Full Text] [Related]
20. Fully automated GMP production of [
Velikyan I; Rosenstrom U; Eriksson O
Am J Nucl Med Mol Imaging; 2017; 7(3):111-125. PubMed ID: 28721305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
